Hilary Seibert
Family Medicine · Stansbury Park, UTNPI 1275623894
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,290 and has fallen 95.2% since, to $62 in 2024.
Across 253 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$858
- Indivior Inc.$382
- AstraZeneca$321
- Boehringer Ingelheim$278
- Mylan Specialty L.p.$254
- Novo Nordisk$234
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,047100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $858 |
| Indivior Inc. | 20 | $382 |
| AstraZeneca | 24 | $321 |
| Boehringer Ingelheim | 18 | $278 |
| Mylan Specialty L.p. | 14 | $254 |
| Novo Nordisk | 16 | $234 |
| Merck | 14 | $202 |
| Lilly USA, LLC | 10 | $144 |
| Alkermes, Inc. | 8 | $121 |
| Antares Pharma, Inc. | 8 | $113 |
| Sanofi-aventis U.S. LLC | 8 | $111 |
| Abbott | 5 | $106 |
| Medtronic(2 entities) | 5 | $83 |
| Neurocrine Biosciences, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $76 |
| Amarin Pharma, Inc. | 4 | $73 |
| Amgen | 4 | $59 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $53 |
| Bayer | 3 | $49 |
| GSK | 3 | $47 |
| Sanofi Pasteur Inc. | 2 | $42 |
| Eisai Inc. | 3 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Dexcom, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 2 | $29 |
| Jazz Pharmaceuticals Inc. | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Organon | 1 | $11 |
How this compares
$4,047 in reported general payments places this provider in the 80th percentile of 928 family medicine providers in Utah.
Other family medicine in Stansbury Park
- Michael CobbleSandy$1.3M
- Thomas ClarkProvidence$332K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- Scott EricksonBountiful$101K
- Mark CacciamaniSalt Lake City$43K
- Clint MowerLehi$41K
- Russell AndersonTooele$30K
- Kirk OdonnellSalt Lake City$23K
- John TemplemanProvo$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.